News & Opinion

Quick Hits: FDA Recommends Recall of Limbrel, Researchers Develop New Methodology for Discovering 2 Types of Cancer

December 14, 2017
Quick Hits: Americans Open to Non-Drug Pain Treatments, Psychiatric Drugs’ Impact on Cognition and Epilepsy Drugs and Pregnancy

FDA recommends voluntary recall of Limbrel capsules. The FDA noted that there have been 194 reports of adverse events, and among those are 2 potentially life-threatening medical conditions: drug-induced liver injury and hypersensitivity pneumonitis. Limbrel is a capsule that is marketed as a marketed as a “medical food to manage Continue Reading →

Task Force Recommends Against Hormone Replacement Therapy for Postmenopausal Women

December 12, 2017

A government task force is reinforcing a recommendation that hormone replacement therapy (HRT) should not be used in postmenopausal women for the prevention of chronic conditions such as heart disease, fractures and dementia.

In 2012, the US Preventive Services Task Force (USPSTF) said the risks of HRT Continue Reading →

Small Increase in Breast Cancer Risk with Use of Hormonal Birth Control

December 11, 2017
Birth Control Pills Linked to Higher Risk of Developing Depression

Women taking birth control have a slightly increased risk of developing breast cancer, according to a study published in the New England Journal of Medicine. The risk increased with the duration of use, but still remained small.

In a nationwide prospective cohort study, researchers from the University Continue Reading →

Quick Hits: Opioid-Driven Hospitalizations Up, Marijuana Not Helping With Opioid Addiction Treatment & More

December 7, 2017
Quick Hits: Americans Open to Non-Drug Pain Treatments, Psychiatric Drugs’ Impact on Cognition and Epilepsy Drugs and Pregnancy

People who are hospitalized because of opioid-driven injuries are 4 times more likely to die than they were in 2000, a Harvard Medical School study reports. Researchers reviewed nationwide data and discovered that more than 35,000 people died from heroin and synthetic opioid overdoses in 2016. Furthermore, deaths in opioid-related Continue Reading →

A Biosimilar OK’d for Breast Cancer Treatment

December 6, 2017
Newer Breast Cancer Meds Have Serious Cardiovascular Risks

The FDA approved Ogivri (trastuzumab-dkst), a biosimilar drug to Herceptin (trastuzumab), to treat patients with breast or metastatic stomach cancer. Ogivri is the first biosimilar approved in the U.S. for the treatment of breast or stomach cancer.

Common side effects associated with Ogivri for the treatment of Continue Reading →

Common Hypertension Med Linked to Skin Cancer Risk

December 5, 2017

Hydrochlorothiazide linked to up to 7 times greater risk of developing squamous cell carcinoma.

Quick Hits: Antidepressants and Lung Damage, Intranasal Analgesics for Kids & More

November 30, 2017
Quick Hits: Americans Open to Non-Drug Pain Treatments, Psychiatric Drugs’ Impact on Cognition and Epilepsy Drugs and Pregnancy

Older people using certain antidepressants are at an increased risk of developing bronchiectasis, a condition where the airways in the lungs become damaged, making it difficult to clear mucus. Researchers involved in the Canadian study analyzed 296 elderly people and reviewed patient records to identify those receiving SSRI and SNRI Continue Reading →